Benitec Biopharma Inc (NASDAQ:BNTC)
| 0.235 Delayed Data As of Mar 16 |  0.0001 / +0.04%Today’s Change | 0.13 Today|||52-Week Range 2.40 | +38.24% Year-to-Date |
Latest BNTC News | Press Releases
No recent news for Benitec Biopharma Inc.
Today’s Trading
| Previous close | 0.24 |
| Today’s open | 0.24 |
| Day’s range | 0.22 - 0.25 |
| Volume | 18,847 |
| Average volume (3 months) | 398,981 |
| Market cap | $6.6M |
Data as of 3:30pm ET, 03/16/2023
Growth & Valuation
| Earnings growth (last year) | +31.05% |
| Earnings growth (this year) | +65.02% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +23.73% |
| P/E ratio | NM |
| Price/Sales | 129.85 |
| Price/Book | 0.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNGXSoligenix Inc | -0.27 | -10.47% |
| PHIOPhio Pharmaceuticals... | +0.05 | +0.88% |
| TMBRTimber Pharmaceutica... | -0.11 | -4.38% |
| ELOXEloxx Pharmaceutical... | +0.39 | +13.00% |
Data as of 3:59pm ET, 03/17/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $73.0K |
| Annual profit (last year) | -$18.2M |
| Net profit margin | -24,942.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
